Moreover, higher levels of inflammasome products, such as IL-18 and Casp1p20, correlated with the severity of the disease and poor clinical outcomes, supporting a role of the NLRP3 inflammasome in COVID-19 pathogenesis and progression (Rodrigues et al., 2021). Here, NLRP3 is linked to COVID-19.